Unraveling the Decline: Search for Factors Behind the Trend in Parkinsons Disease Incidence Rates: A Cohort Study of German Health Claims Data
暂无分享,去创建一个
[1] C. Tanner,et al. Risk of Parkinson Disease Among Service Members at Marine Corps Base Camp Lejeune. , 2023, JAMA neurology.
[2] C. Tanner,et al. Trichloroethylene: An Invisible Cause of Parkinson’s Disease? , 2023, Journal of Parkinson's disease.
[3] S. K. Van Den Eeden,et al. Incidence of Parkinson disease in North America , 2022, NPJ Parkinson's disease.
[4] M. Akmatov,et al. Widening the Spectrum of Risk Factors, Comorbidities, and Prodromal Features of Parkinson Disease , 2022, JAMA neurology.
[5] D. Berg,et al. Cognitive-Driven Activities of Daily Living Impairment as a Predictor for Dementia in Parkinson Disease , 2022, Neurology.
[6] A. Schrag,et al. [Trends in Prevalence of Parkinson's Disease in German General and Neurological Practices from 2010 to 2019]. , 2022, Fortschritte der Neurologie-Psychiatrie.
[7] P. Timpel,et al. [Treatment practice of patients with Parkinson's disease in Saxony : A secondary data-based analysis of utilization in the observation period 2011-2019]. , 2022, Der Nervenarzt.
[8] Hyunwoong Ko,et al. Association between Residential Greenness and Incidence of Parkinson’s Disease: A Population-Based Cohort Study in South Korea , 2022, International journal of environmental research and public health.
[9] Zachary D. Wallen,et al. Oral ingestion of the environmental toxicant trichloroethylene in rats induces alterations in the gut microbiome: relevance to idiopathic Parkinson’s disease , 2022, bioRxiv.
[10] A. Elbaz,et al. Pesticides expenditures by farming type and incidence of Parkinson disease in farmers: a French nationwide study. , 2021, Environmental research.
[11] Zhe-bin Yu,et al. Air pollution, surrounding green, road proximity and Parkinson's disease: a prospective cohort study. , 2021, Environmental research.
[12] B. D. De Miranda,et al. The industrial solvent trichloroethylene induces LRRK2 kinase activity and dopaminergic neurodegeneration in a rat model of Parkinson’s disease , 2020 .
[13] L. G. Vu,et al. Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 , 2020, The Lancet.
[14] M. Brauer,et al. Road proximity, air pollution, noise, green space and neurologic disease incidence: a population-based cohort study , 2020, Environmental health : a global access science source.
[15] Kyoung-Sae Na,et al. Prevalence and incidence of Parkinson’s disease and drug-induced parkinsonism in Korea , 2019, BMC Public Health.
[16] A. Khundakar,et al. Trichloroethylene and its metabolite TaClo lead to degeneration of substantia nigra dopaminergic neurones: Effects in wild type and human A30P mutant α-synuclein mice , 2019, Neuroscience Letters.
[17] F. Vaglini,et al. Parkinson’s disease and light: The bright and the Dark sides , 2019, Brain Research Bulletin.
[18] P. Taba,et al. Incidence and Mortality of Parkinson’s Disease in Estonia , 2019, Neuroepidemiology.
[19] A. Kopp,et al. Time Trends of the Incidence, Prevalence, and Mortality of Parkinsonism , 2019, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[20] B. Bloem,et al. The Emerging Evidence of the Parkinson Pandemic , 2018, Journal of Parkinson's disease.
[21] Vinay Goyal,et al. Parkinson's disease: A review , 2018, Neurology India.
[22] Eyal Oren,et al. Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 , 2017, The Lancet. Neurology.
[23] A. Heintz‐Buschart,et al. The nasal and gut microbiome in Parkinson's disease and idiopathic rapid eye movement sleep behavior disorder , 2017, Movement disorders : official journal of the Movement Disorder Society.
[24] A. Hofman,et al. Trends in the Incidence of Parkinson Disease in the General Population: The Rotterdam Study. , 2016, American journal of epidemiology.
[25] Neng Wan,et al. Parkinson's Disease and Pesticides Exposure: New Findings From a Comprehensive Study in Nebraska, USA. , 2016, The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association.
[26] N. Jetté,et al. The Incidence of Parkinson's Disease: A Systematic Review and Meta-Analysis , 2016, Neuroepidemiology.
[27] M. Quik,et al. Nicotine as a potential neuroprotective agent for Parkinson's disease , 2012, Movement disorders : official journal of the Movement Disorder Society.
[28] C. Tanner,et al. Solvent exposures and parkinson disease risk in twins , 2012, Annals of neurology.
[29] E. Tolosa,et al. Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study , 2008, The Lancet Neurology.
[30] G. Miller,et al. Parkinson's disease and pesticides: a toxicological perspective. , 2008, Trends in pharmacological sciences.
[31] K. Marder,et al. Pooled analysis of tobacco use and risk of Parkinson disease. , 2007, Archives of neurology.
[32] P. S. St George-Hyslop,et al. T313M PINK1 mutation in an extended highly consanguineous Saudi family with early-onset Parkinson disease. , 2006, Archives of neurology.
[33] K. Bötzel,et al. Prevalence and incidence of Parkinson's disease in Europe , 2005, European Neuropsychopharmacology.
[34] Miguel A Hernán,et al. A meta‐analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease , 2002, Annals of neurology.
[35] Robert Gray,et al. A Proportional Hazards Model for the Subdistribution of a Competing Risk , 1999 .
[36] R. Feldman,et al. Environmental Toxins and Parkinson's Disease , 2005 .